Largest pharmaceutical companies in the United States by earnings

Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.

Viatris has the lowest figure of the 44 pharmaceutical companies in the United States ranked by earnings, at -$3.5B, followed by Insmed (-$1.3B) and Summit Therapeutics (-$1.1B). Figures as of 19 Nov 2026, 11:33 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
44
Lowest
Viatris-$3.5B
Median
-$47.8M
Combined market value
$3.81T
Countries
1

Market values as of .

United States
All sectors
Pharmaceuticals
USD
Clear filters
Largest pharmaceutical companies in the United States by earnings
#CompanyEarnings ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ViatrisVTRS · Health Care-$3.5B$23.3B$20.28 0.83% down 96% up United States
2InsmedINSM · Health Care-$1.3B$26.3B$119.80 1.69% down 40% down United States
3Summit TherapeuticsSMMT · Health Care-$1.1B$8.4B$10.50 1.59% down 36% down United States
4CytokineticsCYTK · Health Care-$785M$7.1B$51.32 0.64% down 20% down United States
5BridgeBio PharmaBBIO · Health Care-$732.9M$15.2B$78.01 1.58% up 17% up United States
6Ionis PharmaceuticalsIONS · Health Care-$381.4M$4.6B$27.39 1.59% up 64% down United States
7Cogent BiosciencesCOGT · Health Care-$328.9M$4.8B$27.81 0.14% down 20% down United States
8Praxis Precision MedicinesPRAX · Health Care-$303.3M$8.5B$305.19 0.04% up 61% up United States
9Legend BiotechLEGN · Health Care-$296.8M$3.2B$16.25 0.87% up 42% down United States
10Madrigal PharmaceuticalsMDGL · Health Care-$288.3M$9.2B$398.08 5.67% down 24% down United States
11Elanco Animal HealthELAN · Health Care-$232M$13.3B$26.70 3.29% up 20% up United States
12Rhythm PharmaceuticalsRYTM · Health Care-$196.5M$8.3B$119.04 2.08% up 13% up United States
13Definium TherapeuticsDFTX · Health Care-$183.8M$4B$29.12 0.88% down 169% up United States
14Axsome TherapeuticsAXSM · Health Care-$183.2M$7B$134.00 1.43% down 7% down United States
15Edgewise TherapeuticsEWTX · Health Care-$167.8M$4.5B$41.37 1.59% down 88% up United States
16Dianthus TherapeuticsDNTH · Health Care-$162.3M$4.7B$83.98 3.45% down 113% up United States
17Spyre TherapeuticsSYRE · Health Care-$155.2M$9.6B$101.46 8.15% up 286% up United States
18Protagonist TherapeuticsPTGX · Health Care-$130.1M$8.3B$127.16 2.00% up 46% up United States
19ErascaERAS · Health Care-$124.5M$4.8B$13.76 0.94% down 403% up United States
20Oruka TherapeuticsORKA · Health Care-$105.4M$6.5B$95.74 0.60% down 241% up United States
21Belite BioBLTE · Health Care-$77.6M$6.3B$156.23 0.94% down 31% up United States
22VeradermicsMANE · Health Care-$70M$5.3B$124.86 0.62% down 233% up United States
23Travere TherapeuticsTVTX · Health Care-$25.5M$4.8B$50.24 1.68% down 44% up United States
24Mirum PharmaceuticalsMIRM · Health Care-$23.4M$6B$92.49 0.59% up 31% up United States
25Arrowhead PharmaceuticalsARWR · Health Care-$1.6M$6.1B$43.11 0.28% up 10% up United States
26Amneal PharmaceuticalsAMRX · Health Care$72.1M$7.6B$21.88 3.60% up 83% up United States
27Corcept TherapeuticsCORT · Health Care$99.7M$7.4B$67.79 3.25% down 8% down United States
28Ligand PharmaceuticalsLGND · Health Care$124.5M$6B$298.71 1.67% up 43% up United States
29Alnylam PharmaceuticalsALNY · Health Care$313.7M$20B$149.40 4.54% down 66% down United States
30BioMarin PharmaceuticalBMRN · Health Care$348.9M$11.9B$61.43 4.99% up 11% up United States
31TG TherapeuticsTGTX · Health Care$447.2M$10B$66.12 5.44% up 107% up United States
32PTC TherapeuticsPTCT · Health Care$682.6M$5B$60.23 0.22% down 20% down United States
33Royalty PharmaRPRX · Health Care$770.9M$39.5B$68.67 0.01% down 78% up United States
34United TherapeuticsUTHR · Health Care$1.3B$24.6B$577.34 1.16% down 23% up United States
35ZoetisZTS · Health Care$2.7B$34.8B$85.57 2.50% up 29% down United States
36Vertex PharmaceuticalsVRTX · Health Care$4B$136B$536.45 0.42% up 27% up United States
37AbbVieABBV · Health Care$4.2B$505.6B$286.01 2.33% down 26% up United States
38Regeneron PharmaceuticalsREGN · Health Care$4.5B$97.8B$945.53 1.28% down 36% up United States
39Abbott LaboratoriesABT · Health Care$6.5B$181B$104.48 0.22% down 17% down United States
40Bristol-Myers SquibbBMY · Health Care$7.1B$121.7B$59.56 2.92% down 34% up United States
41PfizerPFE · Health Care$7.8B$159.9B$28.06 1.44% down 14% up United States
42Merck & CoMRK · Health Care$18.3B$339.7B$137.78 3.90% down 51% up United States
43Eli LillyLLY · Health Care$20.6B$1.23T$1,382.75 2.32% down 35% up United States
44Johnson & JohnsonJNJ · Health Care$26.8B$656.5B$272.70 2.15% down 38% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which pharmaceutical companies in the United States have the lowest earnings?

Viatris (-$3.5B), Insmed (-$1.3B) and Summit Therapeutics (-$1.1B) have the lowest earnings of the 44 pharmaceutical companies in the United States ranked here as of 19 Nov 2026, 11:33 UTC.

How many pharmaceutical companies in the United States are in this ranking?

44 are ranked by earnings.

What are these pharmaceutical companies in the United States worth together?

The 44 pharmaceutical companies in the United States ranked by earnings have a combined market value of $3.81T as of 19 Nov 2026, 11:33 UTC.

What does ranking by earnings measure?

Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.

Cite this page

Funkfolio, “Largest pharmaceutical companies in the United States by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=earnings

Underlying data: Yahoo Finance; SEC EDGAR.